In April 2023, the professional team from VCRO assisted the client in submitting new nasal spray drug for asthma treatment for clinical trials to TFDA. The team successfully obtained TFDA approval to proceed with investigator initiated trial (IIT) Phase II clinical trial, helping the client smoothly transition to the phase II clinical trial.
Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial
In April 2023, the professional team from VCRO assisted the client in submitting new nasal spray drug for asthma treatment for clinical trials to TFDA. The team successfully obtained TFDA approval to proceed with investigator initiated trial (IIT) Phase II clinical trial, helping the client smoothly transition to the phase II clinical trial.